newborn respiratory distress syndrome: Infant acute respiratory distress syndrome is a lung disorder that affects premature infants caused by developmental insufficiency of surfactant production and structural immaturity of the lungs. The symptoms usually appear shortly after birth and may include tachypnea, tachycardia, chest wall retractions (recession), expiratory grunting, nasal flaring and cyanosis during breathing efforts.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
536 |
4. Check minimum number of eventsNone |
536 |
5. Include endpointsNone |
536 |
6. Filter based on genotype QC (FinnGen only) |
536 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Dyspnoea neonatalis
Similar endpoints
↥List of similar endpoints to
Respiratory distress of newborn
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 49038 | 21114 | 27923 |
| Only index persons | 18039 | 7483 | 10556 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.70 | 0.60 | 0.78 |
| Only index persons | 0.35 | 0.28 | 0.40 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 536 | 278 | 258 |
| Unadjusted period prevalence (%) | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 456
- Matched controls
- 4260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
4043.7
238.7
214
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
119.4
112
*
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
+∞
113.8
107
*
P07.3
ICD-10 Finland
Other preterm infants
21.7
106.8
167
110
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
14.8
78.5
142
126
WX722
NOMESCO Finland
PEEP
21.4
63.4
97
53
P22.8
ICD-10 Finland
Other respiratory distress of newborn
232.1
43.6
45
*
P07.2
ICD-10 Finland
Extreme immaturity
198.3
37.4
39
*
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
+∞
31.8
31
*
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
311.9
30.4
31
*
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
13.8
30.0
53
40
WX882
NOMESCO Finland
High dependency care
3.8
25.8
131
412
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
+∞
20.4
20
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
4.2
19.7
82
212
602
Kela drug reimbursment
Children's severe malnutrition
5.0
18.6
63
132
H35.1
ICD-10 Finland
Retinopathy of prematurity
+∞
17.4
17
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
17.1
109
393
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
13.7
16.8
29
21
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
34.1
16.2
21
6
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
16.1
119
471
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
154.3
15.1
16
*
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
15.7
14.8
24
15
P29.31
ICD-10 Finland
Persistent fetal circulation
+∞
14.3
14
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.7
13.7
108
439
P07.1
ICD-10 Finland
Other low birth weight
48.1
12.5
15
*
R4110
NOMESCO Finland
Physiotherapy
2.2
12.4
152
775
Z3231
NOMESCO Finland
Registered nurse
2.1
12.4
224
1350
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
7.5
12.4
29
38
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
12.2
12
*
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
7.0
11.8
29
41
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
11.4
68
230
WX730
NOMESCO Finland
Conventional respirator
8.7
11.3
24
27
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
4.7
11.2
38
80
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
114.7
11.2
12
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
10.5
49
139
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
6.8
10.1
25
36
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
9.7
10.1
20
20
J45.1
ICD-10 Finland
Nonallergic asthma
2.6
10.0
82
336
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
7.2
9.8
23
31
P05.0
ICD-10 Finland
Light for gestational age
11.7
9.5
17
14
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
9.3
73
293
Z3226
NOMESCO Finland
Physiotherapist
2.0
9.2
154
875
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
8.1
9.2
20
24
P05.1
ICD-10 Finland
Small for gestational age
6.3
8.5
22
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
8.5
122
648
P25.1
ICD-10 Finland
Pneumothorax originating in the perinatal period
+∞
8.1
8
*
Z2446
NOMESCO Finland
Social worker
2.0
7.9
124
680
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
16.4
7.8
12
7
Z2221
NOMESCO Finland
Medical doctor
1.9
7.8
139
800
RK312
NOMESCO Finland
NA
7.8
7.7
17
21
P70.1
ICD-10 Finland
Syndrome of infant of a diabetic mother
7.4
7.5
17
22
R03BA05
ATC
fluticasone; inhalant
1.8
7.2
142
841
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
4.8
7.2
23
47
R03BA02
ATC
budesonide; inhalant
2.1
7.2
81
390
P21.0
ICD-10 Finland
Severe birth asphyxia
+∞
7.1
7
*
XG413
NOMESCO Finland
Spirometry with oscillometry
3.2
7.1
36
111
H50.30
ICD-10 Finland
Intermittent esotropy
3.8
6.6
27
70
F80.1
ICD-10 Finland
Expressive language disorder
3.0
6.6
37
120
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.9
6.3
109
613
RK520
NOMESCO Finland
NA
9.5
6.3
12
12
R62.0
ICD-10 Finland
Delayed milestone
2.3
6.2
59
260
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
7.8
6.1
13
16
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
17.1
6.0
9
5
P52.0
ICD-10 Finland
Intraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newborn
17.1
6.0
9
5
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022670) pH of Venous cord blood
18
47
3.64
5.59
1.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
8
12
6.26
3.48
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
156
1103
1.44
3.45
11.7
10.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
9
17
4.97
3.30
1.2
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
170
1238
1.40
3.15
13.5
10.2
mmol/l
1.0
0.7
0.68
117
889
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
170
1239
1.40
3.13
13.5
10.3
kpa
5.1
5.0
1.40
161
1203
(3009343) pH of Capillary blood
170
1240
1.40
3.11
13.6
10.3
ph
7.4
7.4
—
5
37
(3005322) IgE [Units/volume] in Serum or Plasma
88
574
1.51
2.90
1.6
1.5
u/ml
257.4
358.5
0.46
83
540
(3004809) Band form neutrophils/100 leukocytes in Blood
15
54
2.62
2.83
2.9
5.9
%
0.6
0.7
—
10
42
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
66
406
1.58
2.82
10.0
9.2
ng/l
44.9
48.7
0.64
66
401
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
13
46
2.66
2.54
1.5
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
183
1388
1.34
2.54
5.0
5.1
e6/l
45.1
23.4
0.54
139
1059
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
161
1200
1.35
2.51
9.8
11.0
umol/l
43.8
29.3
1.99
150
1084
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
123
878
1.39
2.51
3.9
4.2
e6/l
2.5
2.1
0.21
77
519
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
181
1.79
2.50
15.7
11.5
mmol/l
22.6
22.8
0.12
34
171
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
42
2.69
2.40
1.7
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
203
1575
1.32
2.38
8.8
10.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
56
347
1.55
2.34
1.0
1.0
mu/l
9.9
8.3
0.95
51
308
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
70
894
0.68
2.29
2.6
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
66
852
0.68
2.29
2.5
2.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
186
1433
1.31
2.28
5.6
5.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
157
1181
1.33
2.27
12.5
10.0
kpa
9.3
9.8
2.60
148
1145
(3026389) Candida sp identified in Specimen by Organism specific culture
0
55
0.00
2.27
0.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
119
859
1.37
2.25
3.7
4.2
e6/l
0.6
0.9
0.74
72
497
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
44
2.56
2.21
8.2
8.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
56
2.35
2.17
7.4
10.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
171
1317
1.30
2.07
4.7
4.9
e6/l
0.2
0.2
0.21
128
985
(40761511) CBC panel - Blood by Automated count
431
3746
1.37
2.03
10.2
8.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
171
1321
1.30
2.01
4.5
4.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
253
2062
1.26
1.92
9.9
11.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
207
0.44
1.89
1.2
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
18
86
1.97
1.86
2.9
2.7
umol/l
12.3
15.1
1.23
18
86
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
148
1143
1.28
1.72
11.0
10.7
mmol/l
23.5
23.6
0.12
140
1117
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
74
519
1.37
1.68
2.4
2.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
43
273
1.50
1.66
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
43
273
1.50
1.66
1.0
1.0
mmol/l
-3.1
-2.1
0.27
12
61
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
43
273
1.50
1.66
1.0
1.0
kpa
7.4
7.3
0.15
37
234
(3006504) Eosinophils/100 leukocytes in Blood
296
2483
1.24
1.65
9.6
10.9
%
3.2
3.4
0.55
288
2385
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
205
1.57
1.65
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
205
1.57
1.65
1.5
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
390
3380
1.27
1.59
19.5
15.0
mmol/l
4.0
4.0
3.98
382
3261
(3003458) Phosphate [Moles/volume] in Serum or Plasma
138
1067
1.27
1.58
13.2
12.2
mmol/l
1.4
1.4
0.43
133
1015
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
65
2.02
1.58
1.0
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
297
2503
1.23
1.54
10.0
11.0
%
8.3
8.3
0.00
289
2407
(3021706) Oxygen [Partial pressure] in Arterial cord blood
42
270
1.48
1.54
1.0
1.0
kpa
3.5
3.3
0.19
36
232
(3013826) Glucose [Moles/volume] in Serum or Plasma
251
2080
1.23
1.53
12.8
9.4
mmol/l
5.7
6.0
1.21
242
1967
(3013115) Eosinophils [#/volume] in Blood
308
2609
1.23
1.51
10.5
11.8
e9/l
0.2
0.2
0.42
260
2170
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
12
54
2.08
1.47
5.7
7.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
12
54
2.08
1.47
5.4
6.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
159
1.61
1.46
1.3
3.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
300
2540
1.22
1.45
9.8
10.7
e9/l
0.0
0.0
0.64
250
2061
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
248
2062
1.22
1.44
19.5
14.2
mmol/l
1.2
1.2
0.07
239
1937
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
61
2.00
1.44
1.4
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
362
1.40
1.43
1.4
1.4
nmol/l
22.1
20.1
0.42
47
317
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
427
1.37
1.42
2.4
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
43
283
1.44
1.42
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
252
1.47
1.41
2.4
2.6
—
72.8
—
0
11
(3019550) Sodium [Moles/volume] in Serum or Plasma
389
3390
1.24
1.39
19.8
15.1
mmol/l
139.3
139.4
0.49
383
3292
(3022096) Basophils/100 leukocytes in Blood
288
2435
1.21
1.39
9.5
11.0
%
0.6
0.6
0.06
283
2349
(3000494) Fungus identified in Specimen by Culture
48
324
1.41
1.39
1.9
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
27
2.42
1.38
1.1
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
229
0.55
1.37
2.0
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
254
1.46
1.36
2.5
2.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
306
2606
1.21
1.36
9.6
10.7
%
38.4
37.0
1.10
298
2512
(3020393) Adenovirus Ag [Presence] in Stool
23
133
1.63
1.35
1.5
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
140
1104
1.24
1.34
12.3
12.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
181
1467
1.22
1.34
4.9
4.0
nmol/l
70.5
69.3
0.24
175
1395
(3015377) Calcium [Moles/volume] in Serum or Plasma
109
836
1.26
1.33
3.9
3.0
mmol/l
2.4
2.4
0.39
104
761
(3019225) pH of Specimen
19
105
1.70
1.31
2.8
5.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
87
651
1.29
1.30
4.2
4.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
21
120
1.65
1.29
3.6
4.9
umol/l
27.7
23.9
0.67
21
120
(40757494) Bilirubin.total [Moles/volume] in Blood
11
51
2.02
1.26
6.8
3.9
umol/l
121.0
169.7
—
5
27
(3001604) Monocytes [#/volume] in Blood
298
2545
1.20
1.24
9.8
10.7
e9/l
0.6
0.6
1.36
248
2067
(3023323) Follitropin [Units/volume] in Serum or Plasma
48
332
1.37
1.22
2.6
2.4
iu/l
6.8
6.4
0.09
35
193
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
49
596
0.74
1.22
1.8
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
522
0.72
1.21
1.8
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
241
2023
1.19
1.20
20.5
15.8
mmol/l
1.2
1.2
0.17
234
1942
(3019198) Lymphocytes [#/volume] in Blood
304
2606
1.19
1.19
9.8
10.6
e9/l
2.8
2.5
1.15
257
2196
(3021589) Normoblasts [#/volume] in Blood
286
2439
1.19
1.19
11.2
12.6
e9/l
0.0
0.0
0.55
223
1821
(3018010) Neutrophils/100 leukocytes in Blood
298
2552
1.19
1.18
9.3
10.6
%
46.0
47.0
0.65
289
2462
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
1.17
0.0
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
8
37
2.02
1.12
4.6
3.1
mmol/l
1.6
1.6
—
8
37
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
428
1.31
1.12
2.7
2.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
31
202
1.45
1.11
1.5
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
193
1599
1.19
1.10
6.4
6.0
e6/l
57.9
56.8
0.01
143
1092
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
29
2.25
1.10
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
74
556
1.27
1.08
2.0
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
23
142
1.52
1.06
1.5
1.6
nmol/l
1877.4
1091.7
2.24
17
103
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
42
2.00
1.05
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
148
1203
1.20
1.04
14.6
11.1
mmol/l
0.9
1.0
0.16
115
934
(3026008) Bacteria identified in Urine by Culture
104
819
1.22
1.01
3.2
2.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
84
647
1.24
1.01
14.5
15.8
mmol/l
0.8
0.8
1.24
79
622
(3037121) Protein [Mass/volume] in Urine
40
279
1.36
1.00
9.3
8.9
g/l
0.9
0.3
0.95
33
243
(3044889) 12 lead EKG panel
121
1288
0.83
1.00
2.6
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
310
2686
1.17
0.99
11.8
12.6
e9/l
3.3
3.3
0.02
259
2196
(3044640) Blood type and Crossmatch panel - Blood
119
956
1.20
0.95
3.9
4.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
51
1.83
0.91
1.3
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
26
2.15
0.91
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
363
0.73
0.90
1.2
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
39
276
1.33
0.90
1.7
1.8
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
20
125
1.50
0.90
5.9
6.0
ug/l
2.6
2.4
0.15
20
125
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
28
2.00
0.86
1.3
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
28
2.00
0.86
1.3
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
80
626
1.22
0.84
1.6
1.5
pmol/l
107.1
99.0
0.47
36
315
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
29
358
0.74
0.84
1.6
1.4
%
1.4
1.4
0.08
29
325
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
131
1365
0.85
0.84
1.9
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
60
1.71
0.83
2.9
2.5
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
14
82
1.60
0.83
1.7
2.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
53
1.76
0.82
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
64
491
1.24
0.82
18.1
17.5
mmol/l
1.3
1.4
0.49
58
440
(44813793)
15
90
1.56
0.81
1.1
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
160
1.41
0.80
15.4
14.9
u/ml
121.5
253.4
—
6
23
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
45
334
1.27
0.76
2.1
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
43
495
0.79
0.76
1.7
1.8
—
—
—
0
0
(3049233) Organic acids panel - Urine
9
50
1.68
0.75
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
57
437
1.23
0.74
1.7
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
181
0.66
0.74
1.2
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
14
85
1.54
0.73
5.1
5.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
23
2.02
0.73
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
23
2.02
0.73
1.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
52
1.61
0.72
1.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
52
1.61
0.72
1.0
1.3
—
—
—
0
0
(4306422)
9
52
1.61
0.72
1.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
132
1.42
0.72
3.1
2.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
49
371
1.25
0.72
2.6
2.4
u/l
4.7
4.9
0.07
31
202
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
140
1.41
0.71
7.1
3.1
—
—
—
0
0
(4034850)
7
37
1.76
0.71
9.3
7.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
39
450
0.79
0.71
1.5
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
53
1.58
0.71
4.0
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
53
1.58
0.71
1.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
53
1.58
0.71
1.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
53
1.58
0.71
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
53
1.58
0.71
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
53
1.58
0.71
7.4
3.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
449
0.79
0.70
1.5
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
165
1.36
0.69
2.2
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
239
1.30
0.68
1.8
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
85
0.54
0.68
4.4
2.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
208
2071
0.89
0.67
2.2
2.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
44
332
1.25
0.67
2.2
2.2
u/ml
161.1
153.3
0.04
19
146
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
189
1617
1.13
0.66
3.1
2.9
mmol/l
1.1
1.1
0.07
178
1539
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
26
1.79
0.66
4.0
7.1
ug/l
199.6
247.5
—
5
26
(3016879) Cocaine [Presence] in Urine
37
424
0.79
0.65
1.5
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
40
453
0.80
0.64
1.5
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
73
1.54
0.63
1.3
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
160
1.35
0.63
2.1
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
300
0.76
0.63
1.7
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
40
452
0.81
0.62
1.5
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
45
1.66
0.62
1.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
46
1.62
0.62
1.1
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
103
850
1.15
0.61
3.9
4.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
28
1.66
0.61
2.0
2.9
umol/l
24.5
16.7
—
5
28
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
28
1.66
0.61
1.0
1.8
—
—
—
0
0
(4094501)
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
157
1579
0.89
0.59
6.6
6.0
ml/min/173m2
114.7
114.6
0.02
93
911
(40768797) Stomach Pathology biopsy report
33
245
1.27
0.59
1.5
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
521
1.18
0.56
6.5
10.4
umol/l
5.4
6.3
0.58
51
434
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
344
0.80
0.55
1.2
1.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
12
76
1.47
0.54
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
429
3877
1.14
0.53
12.6
11.9
mg/l
23.5
24.6
0.27
281
2588
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
157
0.70
0.53
2.8
6.7
%
102.6
95.1
0.44
12
157
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
9
58
1.45
0.53
1.8
3.1
umol/l
57.4
57.2
—
9
58
(1001926) Buprenorphine [Presence] in Urine by Screen method
32
362
0.81
0.52
1.5
1.8
—
—
—
0
0
(44790048)
24
174
1.29
0.52
3.5
2.2
—
—
—
0
0
(44790049)
24
174
1.29
0.52
3.5
2.2
—
—
—
0
0
(44790047)
24
174
1.29
0.52
3.5
2.2
—
—
—
0
0
(44806118)
24
174
1.29
0.52
3.5
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
30
225
1.25
0.51
8.5
6.5
%
0.4
0.5
0.24
15
80
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
62
1.50
0.50
1.0
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
118
1.35
0.49
9.0
8.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
43
1.52
0.48
4.6
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
207
1810
1.10
0.47
4.1
3.5
ug/l
59.1
48.9
0.52
199
1721
(4035726)
27
202
1.25
0.47
1.9
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
119
1.34
0.47
2.7
2.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
79
1.42
0.46
1.3
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
58
470
1.16
0.46
1.3
1.6
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
46
1.42
0.45
7.3
6.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
46
1.42
0.45
1.3
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
71
736
0.88
0.44
5.2
4.3
ph
7.4
7.4
—
9
118
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
72
1.43
0.44
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
129
1.30
0.43
1.3
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
243
0.79
0.43
2.4
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
29
1.60
0.43
1.2
1.9
pmol/l
139.2
149.5
—
5
29
(3005011) Chlamydia sp Ab [Titer] in Serum
5
29
1.60
0.43
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
64
666
0.88
0.42
5.2
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
138
1.29
0.42
7.7
3.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
54
1.38
0.41
2.6
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
54
1.38
0.41
18.3
9.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
89
1.36
0.41
2.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.41
0.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.41
0.0
1.9
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
3.9
—
0.5
—
0
14
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.41
0.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.41
0.0
1.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.0
—
3.6
—
0
15
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
81
1.38
0.41
2.5
2.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
27
206
1.23
0.41
3.2
2.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
27
206
1.23
0.41
8.5
6.7
%
0.0
0.0
0.00
12
65
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
27
207
1.22
0.40
8.2
5.5
%
0.4
0.4
—
10
57
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
123
1.29
0.39
4.6
3.0
—
788.6
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
388
0.85
0.38
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
208
1.21
0.38
3.4
2.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
5
34
1.37
0.37
27.4
5.2
%
0.9
0.9
—
5
29
(40768804) Tissue Pathology biopsy report
75
630
1.12
0.37
1.8
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
91
1.33
0.37
5.2
4.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
23
175
1.23
0.36
18.5
22.2
%
95.8
96.3
0.16
23
175
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
175
1.23
0.36
17.3
11.9
iu/ml
60.0
362.7
—
5
25
(4010399)
26
201
1.21
0.36
1.6
1.6
—
—
—
0
0
(3013512) EKG study
31
336
0.85
0.36
2.3
2.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
113
0.73
0.35
1.6
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
114
0.73
0.35
1.2
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
23
176
1.22
0.35
18.5
22.1
%
0.7
0.8
0.54
23
176
(3013139) Helicobacter pylori Ag [Presence] in Stool
23
176
1.22
0.35
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
21
159
1.23
0.35
12.9
14.6
g/l
115.7
123.5
0.63
21
154
(3003694) ABO and Rh group [Type] in Blood
114
1133
0.91
0.35
1.6
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
28
305
0.84
0.34
2.1
2.5
u/l
24.9
28.1
0.44
23
243
(3000850) Epithelial cells [#/volume] in Urine
107
921
1.10
0.34
4.5
3.9
e6/l
6.4
5.8
0.20
95
800
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
41
1.36
0.34
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
80
0.69
0.33
3.2
2.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
16
184
0.80
0.33
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
194
0.81
0.33
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
313
0.85
0.32
1.2
1.1
u/ml
1.0
8.3
—
6
78
(3007566) Smooth muscle Ab [Titer] in Serum
7
92
0.70
0.31
2.3
2.7
—
57.9
—
0
14
(3016031) Almond IgE Ab [Units/volume] in Serum
7
49
1.33
0.31
1.3
1.1
u/ml
1.0
2.2
—
7
41
(3007164) IgA [Mass/volume] in Serum or Plasma
205
1822
1.07
0.30
1.8
1.7
g/l
1.3
1.4
0.70
106
902
(3010813) Leukocytes [#/volume] in Blood
484
4438
1.13
0.30
19.9
17.5
e9/l
7.3
7.1
0.61
463
4165
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
447
0.88
0.30
3.1
4.4
ng/l
1008.9
1319.9
0.30
31
270
(3014051) Protein [Presence] in Urine by Test strip
12
86
1.30
0.30
1.9
1.6
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
16
120
1.24
0.29
2.0
1.8
umol/l
3.7
3.5
0.09
16
105
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
120
1.24
0.29
1.3
1.3
ug/g
440.0
380.4
—
8
62
(3002256) Pathology report gross observation
29
232
1.17
0.29
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
33
267
1.16
0.29
3.1
2.2
nmol/l
9.6
9.1
0.08
26
189
(3000330) Specific gravity of Urine by Test strip
15
112
1.25
0.29
2.9
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
120
1048
1.08
0.28
3.9
3.5
mg/l
2.7
2.7
0.02
107
955
(36660697) Celiac disease serology panel - Serum
97
840
1.09
0.28
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
121
1.23
0.28
2.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
114
995
1.08
0.27
4.6
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
32
336
0.88
0.26
1.2
1.2
iu/ml
13.3
15.5
—
6
71
(21494434) Karyotype in Bone marrow
5
68
0.68
0.26
1.0
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
42
350
1.12
0.25
6.1
7.4
umol/l
298.4
1136.6
0.47
42
338
(3022145) Colonoscopy Study observation
20
157
1.19
0.25
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
97
1.25
0.25
1.2
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
71
1.18
0.24
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
69
593
1.09
0.24
1.9
1.9
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
371
3376
1.06
0.24
9.7
10.0
u/l
31.4
25.1
1.15
364
3254
(46235355) HIV 1 and 2 tests - Meaningful Use set
87
859
0.93
0.24
1.7
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
216
1936
1.06
0.24
6.2
5.5
u/l
160.1
149.6
0.65
204
1817
(3029937) Albumin [Presence] in Urine by Test strip
81
702
1.08
0.24
6.0
3.7
estimate
0.0
0.0
0.00
23
234
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
640
0.92
0.24
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
65
558
1.09
0.24
4.3
7.0
mg/l
1.6
2.4
0.68
48
416
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
225
0.86
0.23
1.1
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
28
229
1.14
0.23
2.4
3.2
mu/l
14.3
20.0
0.70
28
217
(3002385) Erythrocyte distribution width [Ratio]
424
3877
1.07
0.23
19.3
17.4
%
13.3
13.2
1.91
419
3813
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
85
0.76
0.22
6.3
3.8
e9/l
3.7
3.1
—
7
85
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
86
0.75
0.22
2.4
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
87
0.74
0.22
6.7
4.4
%
48.7
48.2
—
7
87
(3034770) Mitochondria Ab [Titer] in Serum
7
88
0.73
0.22
2.3
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
88
0.73
0.22
2.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
168
1.17
0.22
1.7
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
26
212
1.14
0.22
9.3
6.6
%
0.1
0.1
0.01
15
73
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
165
0.84
0.22
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
38
1.22
0.22
32.2
5.3
%
1.5
1.3
—
5
33
(3020891) Body temperature
11
82
1.25
0.21
14.7
7.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
303
2747
1.05
0.21
3.5
3.2
pmol/l
14.6
14.4
0.77
280
2493
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
443
4152
0.93
0.21
3.9
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
83
724
1.07
0.21
7.6
5.0
inr
1.1
1.1
0.23
19
161
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
6.6
—
1.8
—
0
11
(3026782) Osmolality of Urine
104
915
1.07
0.21
4.1
3.7
mosm/kgh2o
581.2
601.5
0.29
91
789
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
15
164
0.84
0.21
2.2
2.3
nmol/l
0.4
0.5
0.08
15
144
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
213
0.87
0.21
1.5
1.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
28
231
1.13
0.20
2.0
1.8
mmol/l
2.4
2.4
0.59
21
192
(3006462) Nitrate [Presence] in Urine
0
13
0.00
0.20
0.0
1.4
—
—
—
0
0
(4211845)
0
13
0.00
0.20
0.0
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
13
100
1.21
0.20
1.1
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
45
1.24
0.20
1.0
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
106
0.78
0.20
3.1
4.0
ug/l
439.6
388.6
—
9
96
(3026361) Erythrocytes [#/volume] in Blood
482
4432
1.09
0.20
19.9
17.4
e12/l
4.6
4.6
0.28
464
4145
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
192
1836
0.95
0.20
2.5
2.0
mmol/l
5.4
5.3
0.75
174
1665
(3015736) pH of Urine
126
1218
0.95
0.19
5.0
3.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
24
197
1.14
0.19
3.2
2.8
pmol/l
5.7
5.2
1.15
24
179
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
23
240
0.88
0.19
1.1
1.1
u/ml
2.6
0.2
0.62
13
117
(3051651) Icteric interference index of Serum or Plasma
11
84
1.22
0.18
5.5
4.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
32
270
1.10
0.17
2.1
2.1
—
11.3
—
0
12
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
58
1.12
0.17
1.1
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
64
0.72
0.17
1.2
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
65
0.71
0.17
1.8
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
63
1.18
0.16
1.1
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
8
63
1.18
0.16
1.0
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
111
1.17
0.16
7.1
3.5
ml/min/173m2
68.5
93.2
—
6
21
(3044290) Cell count panel - Cerebral spinal fluid
21
173
1.13
0.16
5.8
5.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
208
1880
1.04
0.16
1.8
1.9
u/ml
2.9
4.7
0.87
35
306
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
67
1.11
0.16
1.1
1.2
—
0.2
—
0
5
(3048689) Calprotectin [Mass/mass] in Stool
89
863
0.95
0.16
2.9
3.5
ug/g
158.5
85.4
0.38
73
703
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
74
0.75
0.15
2.7
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
73
1.15
0.15
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
481
4429
1.08
0.15
20.0
17.5
e9/l
278.9
276.2
0.32
463
4161
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
175
1578
1.04
0.15
3.4
3.2
mmol/mol
35.0
36.4
0.93
162
1487
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
62
607
0.94
0.15
1.6
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
139
0.86
0.14
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
44
381
1.08
0.14
2.2
2.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
18
148
1.13
0.14
31.3
24.0
%
76.1
71.3
0.90
18
148
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
129
0.86
0.14
2.0
1.5
g/l
0.6
0.7
0.37
12
114
(3019150) Specific gravity of Urine by Refractometry
82
727
1.05
0.14
5.1
2.9
kg/l
1.0
1.0
0.44
18
161
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
96
1.16
0.13
3.4
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
224
0.91
0.13
5.5
4.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
27
230
1.09
0.12
18.7
17.9
kpa
14.9
16.0
0.33
27
223
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
43
375
1.07
0.12
2.1
2.3
ng/l
15.6
49.5
1.53
20
141
(3009542) Hematocrit [Volume Fraction] of Blood
444
4085
1.05
0.12
18.6
17.2
%
38.9
38.7
0.59
411
3712
(3009261) Glucose [Presence] in Urine by Test strip
164
1557
0.97
0.12
5.3
3.6
estimate
0.0
0.0
0.00
25
243
(3023410) Appearance of Cerebral spinal fluid
15
156
0.89
0.12
7.5
5.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
21
177
1.10
0.12
5.8
4.7
mmol/l
2.9
3.2
1.09
21
171
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
27
231
1.09
0.12
18.7
17.8
kpa
5.3
5.5
0.41
27
224
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
133
1201
1.04
0.11
5.1
4.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
163
1544
0.97
0.10
7.5
5.4
estimate
0.0
0.0
0.00
24
247
(40760892) CBC W Ordered Manual Differential panel - Blood
78
697
1.04
0.10
7.8
5.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
254
2389
0.97
0.10
4.2
4.8
mm/h
8.1
7.1
0.71
244
2239
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
116
0.88
0.10
1.2
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
40
1.16
0.10
1.0
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
40
1.16
0.10
2.6
2.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
40
1.16
0.10
1.0
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
40
1.16
0.10
1.0
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
46
448
0.95
0.10
1.2
1.2
u/ml
3.6
4.3
0.09
18
157
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
179
1.09
0.10
5.9
4.9
e6/l
53.4
7.0
0.42
16
125
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
20
170
1.09
0.09
5.1
3.6
%
23.2
24.8
0.32
20
170
(3024928) Oxygen saturation in Venous blood
18
152
1.10
0.09
36.3
23.3
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
19
161
1.10
0.09
1.3
1.2
u/ml
0.3
0.9
—
6
52
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
50
1.11
0.09
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
180
1698
0.97
0.09
3.2
2.8
mmol/l
1.3
1.4
0.77
167
1607
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
81
1.15
0.09
1.2
1.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
52
1.07
0.08
1.2
1.9
%
133.0
117.3
—
6
52
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
162
1.09
0.08
1.9
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
54
1.03
0.08
1.8
2.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
238
0.93
0.08
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
162
0.91
0.08
1.8
1.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
58
0.80
0.08
1.0
2.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
59
1.10
0.08
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
59
1.10
0.08
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
59
1.10
0.08
1.3
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
59
1.10
0.08
1.3
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
61
1.06
0.08
7.0
5.3
ug/l
29.1
24.1
—
7
61
(3014599) Egg white IgE Ab [Units/volume] in Serum
21
209
0.93
0.08
1.4
1.5
u/ml
12.8
10.3
0.08
15
153
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
68
0.82
0.07
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
68
1.09
0.07
1.1
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
118
1.10
0.07
1.2
1.3
miu/ml
250.3
218.2
—
9
46
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
77
0.84
0.07
1.6
4.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
77
0.84
0.07
1.6
4.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
9
79
1.06
0.07
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
84
0.88
0.07
2.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
94
0.89
0.06
1.0
1.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
179
0.93
0.06
1.7
2.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
51
489
0.96
0.06
1.3
1.3
u/ml
4.3
2.8
0.25
37
335
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
92
1.11
0.06
1.9
1.7
ug/l
9.5
6.7
0.30
11
84
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
36
320
1.05
0.06
1.4
1.3
iu/ml
241.8
148.3
—
8
88
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
64
577
1.03
0.06
1.8
2.0
mmol/l
1.5
1.2
0.95
58
536
(3003740) Influenza virus B Ag [Presence] in Specimen
20
174
1.07
0.06
1.2
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
18
178
0.94
0.05
5.3
3.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
178
0.94
0.05
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
138
1.08
0.05
1.6
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
20
175
1.06
0.05
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
148
1.07
0.04
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
27
261
0.96
0.04
1.1
1.1
u/ml
14.2
10.5
0.25
18
162
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
121
1.07
0.04
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
37
332
1.04
0.04
1.5
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
138
0.94
0.03
1.1
1.6
—
13.0
—
0
5
(3037467) Urinalysis macro (dipstick) panel - Urine
241
2220
1.01
0.03
5.3
4.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
23
222
0.96
0.03
1.1
1.6
u/ml
3.2
3.9
0.08
18
165
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
188
1756
0.99
0.03
3.3
3.0
mmol/l
4.2
4.2
0.43
174
1675
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
122
1.07
0.03
6.0
4.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
113
1.07
0.02
42.8
28.9
%
11.0
11.7
0.41
13
113
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
249
0.97
0.02
1.2
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
86
1.08
0.02
1.6
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
202
0.96
0.02
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
123
1.06
0.02
2.1
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
29
276
0.97
0.01
1.1
1.1
u/ml
13.2
7.3
0.47
19
167
(3000492) Spirometry study
26
234
1.03
0.01
1.2
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
49
461
0.98
0.01
1.2
1.2
u/ml
5.8
5.3
0.11
38
356
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
124
1.05
0.01
12.2
29.4
u/ml
0.2
0.3
—
7
83
(3016018) Differential panel - Cerebral spinal fluid
14
124
1.05
0.01
4.4
4.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
329
3056
0.99
0.00
4.0
3.5
mu/l
2.2
2.1
1.51
311
2885
(1616796) Gas panel - Central venous blood
10
98
0.94
0.00
13.7
6.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
16
143
1.04
0.00
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
184
1711
1.00
0.00
3.2
2.8
mmol/l
2.6
2.6
0.14
171
1604
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
135
0.96
0.00
2.1
2.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
160
0.98
0.00
22.9
21.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
160
0.98
0.00
1.6
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
155
1.02
0.00
4.6
3.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
303
1.01
0.00
2.5
2.5
u/l
93.7
7922.6
—
5
77
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
67
620
1.00
0.00
4.8
3.3
u/l
46.9
57.1
2.14
62
574
(3023520) Reticulocytes [#/volume] in Blood
53
492
1.00
0.00
4.1
5.5
e9/l
60.7
62.9
0.23
37
291
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
119
1.01
0.00
2.3
1.9
%
33.1
31.7
—
8
87
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
94
0.99
0.00
1.5
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
94
0.99
0.00
1.5
1.2
%
76.7
72.8
—
10
94
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
19
180
0.98
0.00
5.3
3.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
177
0.99
0.00
1.7
1.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
107
1.04
0.00
2.0
1.3
g/l
1.8
2.0
0.54
12
96
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
107
1.04
0.00
2.0
1.3
g/l
5.2
6.0
0.67
12
95
(4062490)
12
107
1.04
0.00
2.0
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
106
0.96
0.00
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
15
139
1.00
0.00
1.5
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
20
186
1.00
0.00
4.9
3.6
e6/l
557.3
408.7
0.58
15
120
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
161
0.98
0.00
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
49
453
1.00
0.00
1.2
1.2
u/ml
1.3
0.8
0.36
36
337
(42529406) Shigella sp [Presence] in Stool by Culture
14
127
1.02
0.00
1.1
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
20
182
1.02
0.00
5.2
3.7
%
66.7
65.5
0.12
20
182
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
182
1.02
0.00
5.2
3.6
%
10.7
9.1
0.35
20
171
(3035350) Ketones [Presence] in Urine by Test strip
167
1548
1.00
0.00
5.3
3.6
estimate
0.0
0.0
0.00
24
227
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
104
963
1.00
0.00
5.3
3.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
125
0.96
0.00
1.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
51
0.91
0.00
23.4
5.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
0.7
—
0
8
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
15.0
—
0
6
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
56
0.99
0.00
1.2
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
82
0.90
0.00
1.5
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
71
0.91
0.00
10.7
9.2
kpa
10.1
9.3
—
7
71
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
48
0.97
0.00
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
21.9
—
0
9
(40757373) Influenza virus identified in Isolate
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
62
0.90
0.00
2.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
55
1.01
0.00
1.2
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.3
—
34.2
—
0
6
(4146454)
0
6
0.00
0.00
0.0
3.7
—
—
—
0
0
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
69
0.94
0.00
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
7
71
0.91
0.00
10.7
9.2
kpa
5.0
4.8
—
7
71
(3034860) Kappa light chains.free [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
23.1
—
0
9
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
208.0
—
0
5
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
64.6
—
0
9
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
79
0.94
0.00
2.8
1.7
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
39.9
—
0
8
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
240.7
—
0
9
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
5
50
0.93
0.00
1.2
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
1.6
—
1818.8
—
0
8
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
76.1
—
0
5
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
2.2
—
1492.7
—
0
6
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
81
0.91
0.00
2.0
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
67
0.97
0.00
1.6
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
51
0.91
0.00
1.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
52
0.89
0.00
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
7
68
0.95
0.00
1.1
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
68
0.95
0.00
1.3
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
67
0.97
0.00
1.6
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_RESPI_DISTR_NEWBO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_RESPI_DISTR_NEWBO | 1.873 [1.51, 2.32] | < 0.001 |
| Birth year | 0.996 [0.99, 1.01] | 0.39 |
During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 19773 females with P16_RESPI_DISTR_NEWBO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_RESPI_DISTR_NEWBO | 1.898 [1.59, 2.26] | < 0.001 |
| Birth year | 0.985 [0.97, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 164 out of 26033 males with P16_RESPI_DISTR_NEWBO died.
Mortality risk
Mortality risk for people of age
years, who have P16_RESPI_DISTR_NEWBO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.196% | 0.286% |
| 5 | 1.099% | 1.786% |
| 10 | 2.779% | 4.573% |
| 15 | 5.361% | 8.709% |
| 20 | 9.471% | 14.853% |
Relationships between endpoints
↥Index endpoint: P16_RESPI_DISTR_NEWBO – Respiratory distress of newborn
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data